Some literatures have shown that TRIM23, a member of the E3 ubiquitin ligase TRIM family, acts as an oncogene in lung adenocarcinoma (LUAD) and regulates glucose metabolism through the TRIM23/NF- κ B/GLUT1/3 axis to promote DDP drug resistance [5]. This evidence concerns the gene TRIM23 and lung adenocarcinoma.